» Articles » PMID: 3843690

Undifferentiated and Poorly Differentiated Carcinoma

Overview
Date 1985 May 1
PMID 3843690
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Undifferentiated (anaplastic) thyroid carcinoma is a highly aggressive neoplasm which may simulate microscopically a variety of soft tissue sarcomas. The three major subtypes are spindle cell, giant cell, and squamoid. Electron microscopic examination and immunocytochemical stain for cytokeratin are the most useful special techniques to document the epithelial nature of the tumor. Undifferentiated small-cell carcinoma is a term to be discarded. Nearly all tumors so designated in the past are malignant lymphomas, small-cell variants of medullary carcinomas, or poorly differentiated (insular) carcinomas. Poorly differentiated (insular) carcinoma is a thyroid malignant tumor characterized by the formation of solid nests and small follicles, a monotonous growth of small cells of follicular derivation, mitotic activity, necrosis, and peritheliomatous formation. Immunocytochemically, it is negative for calcitonin and positive for thyroglobulin. It is a clinically aggressive neoplasm, which metastasizes to both regional lymph nodes and distant organs. It is probably analogous to the tumor described by Langhans in 1907 as "wuchernde Struma."

Citing Articles

Rare Manifestations of Anaplastic Thyroid Carcinoma: the Role of BRAF Mutation Analysis.

Song Y, Jung C, Jung K, Park Y, Won J J Korean Med Sci. 2017; 32(10):1721-1726.

PMID: 28875621 PMC: 5592191. DOI: 10.3346/jkms.2017.32.10.1721.


Undetectable Thyroglobulin Levels in Poorly Differentiated Thyroid Carcinoma Patients Free of Macroscopic Disease After Initial Treatment: Are They Useful?.

Ibrahimpasic T, Ghossein R, Carlson D, Nixon I, Palmer F, Patel S Ann Surg Oncol. 2015; 22(13):4193-7.

PMID: 25893415 PMC: 4976496. DOI: 10.1245/s10434-015-4567-3.


Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer.

Ragazzi M, Ciarrocchi A, Sancisi V, Gandolfi G, Bisagni A, Piana S Int J Endocrinol. 2014; 2014:790834.

PMID: 25214840 PMC: 4158294. DOI: 10.1155/2014/790834.


Recent advances in molecular diagnosis of thyroid cancer.

Legakis I, Syrigos K J Thyroid Res. 2011; 2011:384213.

PMID: 21603167 PMC: 3095897. DOI: 10.4061/2011/384213.


Re-evaluation of histopathological factors affecting prognosis of differentiated thyroid carcinoma in an iodine-sufficient country.

Sugitani I, Toda K, Yamamoto N, Sakamoto A, Fujimoto Y World J Surg. 2009; 34(6):1265-73.

PMID: 19953247 DOI: 10.1007/s00268-009-0305-y.